NASDAQ · FTXH
First Trust Nasdaq Pharmaceuticals ETF
$44.24+$0.47 (+1.07%)
First Trust Nasdaq Pharmaceuticals ETF’s quoted price sits in the upper half of its reported 52-week range, 1.21% below the high.
Loading market information…
NASDAQ · RNEM · USD
Stock price, dividends
Quote as of Oct 30, 2026, 08:00 PM UTC. Cached market data; not a live quote.
One-year closing-price history · USD. Historical prices are not a forecast.
First Trust Emerging Markets Equity Select ETF’s quoted price sits in the upper half of its reported 52-week range, 6.03% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE INCOME SIDE
First Trust Emerging Markets Equity Select ETF’s forward annual dividend is $2.54 per share, paid quarterly. The forward yield is 4.58% at the quoted price. Future payments can change.
Historical amounts are adjusted for stock splits. Understand ex-dividend and payment dates →
THE COMPANY BEHIND THE TICKER
RNEM seeks stability by filtering the universe of large- and midcap emerging-market stocks for companies with historically low volatility of returns. Within each emerging market country, the fund selects the 25 stocks with the lowest volatility over the previous 12 months. The resulting portfolio is sorted into country/sector buckets, with each bucket set to market weight at each rebalance. Holdings are equal-weighted within the buckets. The funds use of a NASDAQ parent index means that it classifies both South Korea and Taiwan as emerging markets, which may not align with how they are classified in other emerging-market funds. The index is reconstituted and rebalanced semi-annually.
Latest available per-share figures in USD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 31, 2026, 05:21 PM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
Completed calendar years and any current-year payments shown separately. Current-year totals are incomplete until all payments are made.
See annual income at the current dividend rate.
Assumes the annual dividend stays unchanged. Payments follow the company’s schedule. Excludes taxes, fees and currency changes.
KEEP COMPARING
$44.24+$0.47 (+1.07%)
First Trust Nasdaq Pharmaceuticals ETF’s quoted price sits in the upper half of its reported 52-week range, 1.21% below the high.
$84.68-$1.34 (-1.56%)
First Trust Alerian U.S. NextGen Infrastructure ETF’s quoted price sits in the upper half of its reported 52-week range, 7.02% below the high.
$23.56-$0.43 (-1.81%)
First Trust Latin America AlphaDEX Fund’s quoted price sits in the lower half of its reported 52-week range, 17.32% below the high.
$47.86-$0.25 (-0.52%)
Leuthold Select Industries ETF’s quoted price sits in the upper half of its reported 52-week range, 6.8% below the high.
$77.25-$2.99 (-3.73%)
Putnam Emerging Markets Ex-China ETF’s quoted price sits in the lower half of its reported 52-week range, 18.85% below the high.
$28.93+$0.05 (+0.19%)
Virtus Real Asset Income ETF’s quoted price sits in the upper half of its reported 52-week range, 1.3% below the high.
$22.83+$0.47 (+2.09%)
First Trust Nasdaq Food & Beverage ETF’s quoted price sits in the upper half of its reported 52-week range, 4.68% below the high.
$48.29+$0.37 (+0.76%)
First Trust Bloomberg Shareholder Yield ETF’s quoted price sits in the upper half of its reported 52-week range, 0.43% below the high.
